News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Michelle M. Boisen, MD

Articles by Michelle M. Boisen, MD

Dr. Boisen on Scoring System for Optimal Debulking in Ovarian Cancer

ByMichelle M. Boisen, MD

April 7th 2020

Michelle M. Boisen, MD, discusses the scoring system for optimal debulking in ovarian cancer.

Dr. Boisen on Selecting Patients for Surgery Versus Neoadjuvant Chemotherapy in Ovarian Cancer

ByMichelle M. Boisen, MD

April 6th 2020

Michelle M. Boisen, MD, discusses criteria for selecting patients with ovarian cancer for upfront surgery versus neoadjuvant chemotherapy.

Dr. Boisen on Neoadjuvant Chemotherapy Versus Upfront Surgery in Ovarian Cancer

ByMichelle M. Boisen, MD

January 28th 2020

Michelle M. Boisen, MD, discusses the selection of neoadjuvant chemotherapy versus upfront surgery for women with newly diagnosed ovarian cancer.

Latest Updated Articles

Dr. Boisen on Neoadjuvant Chemotherapy Versus Upfront Surgery in Ovarian Cancer
January 28th 2020
Dr. Boisen on Selecting Patients for Surgery Versus Neoadjuvant Chemotherapy in Ovarian Cancer
April 6th 2020
Dr. Boisen on Scoring System for Optimal Debulking in Ovarian Cancer
April 7th 2020

Trending on OncLive

HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA

Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg

Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL

Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis

ESAONA Data Support Asandeutertinib as a Frontline Option in EGFR+ NSCLC With Brain Metastases